Gastroenteritis in Children
Gastroenteritis in children is usually a self-limiting viral illness causing vomiting and diarrhoea, with the main risk being dehydration, particularly in infants.
Key Facts
Rotavirus was the most common cause before vaccination; now norovirus is the leading cause in UK children Rotavirus vaccine (Rotarix) introduced in the UK schedule in 2013 — given at 8 and 12 weeks; reduced rotavirus hospitalisations by ~80% NICE CG84 guides assessment and management of diarrhoea and vomiting in children under 5 Oral rehydration solution (ORS) is the mainstay of treatment — low-osmolality ORS (e.g., Dioralyte) is recommended IV fluids indicated for clinical signs of shock or if ORS is not tolerated/not effective Antibiotics are NOT routinely indicated; consider only for specific bacterial causes (e.g., shigella, cholera, severe salmonella in immunocompromised) Stool culture recommended if bloody diarrhoea, immunocompromised, recent travel, or symptoms >7 days Approximately 10% of children under 5 present to healthcare annually with gastroenteritis in the UK
Overview
Key Facts
Gastroenteritis is one of the most common childhood illnesses worldwide. In the UK, it is usually self-limiting and caused by viral pathogens. The main risk is dehydration, particularly in young infants and those with high stool output. Management focuses on fluid replacement and nutritional maintenance.
Epidemiology
Gastroenteritis causes approximately 1.5 million GP consultations annually in UK children under 5. Before rotavirus vaccination (2013), rotavirus caused approximately 18,000 hospitalisations per year in England. Since vaccine introduction, rotavirus hospitalisations have fallen by approximately 80%. Norovirus is now the leading viral cause. Peak incidence is in winter months (norovirus, rotavirus) and summer (bacterial causes).
Aetiology
Viral (70-80%):
- Norovirus (most common post-rotavirus vaccination era)
- Rotavirus (declining with vaccination)
- Adenovirus (serotypes 40/41)
- Astrovirus, sapovirus
Bacterial (15-20%):
- Campylobacter (most common bacterial cause in UK)
- Salmonella
- Shigella
- E. coli (including STEC/O157 — associated with HUS)
Parasitic (rare in UK):
- Giardia lamblia, Cryptosporidium
Pathophysiology
Viral: Direct enterocyte invasion → villous blunting → reduced absorptive surface area → osmotic diarrhoea. Also disrupts brush border disaccharidases → temporary lactose intolerance.
Bacterial: Enterotoxin-mediated (watery diarrhoea — cholera, ETEC) or invasive (bloody diarrhoea — Shigella, Campylobacter, EIEC). Inflammation damages colonic mucosa.
STEC (E. coli O157): Produces Shiga toxin → endothelial damage → thrombotic microangiopathy → haemolytic uraemic syndrome (HUS) in ~5-10% of infected children.
Clinical Presentation
Typical Presentation
- Acute onset diarrhoea (≥3 loose/watery stools per day)
- Vomiting (often precedes diarrhoea)
- Fever (low-grade, especially viral)
- Abdominal cramps
- Reduced oral intake
Dehydration Assessment (NICE CG84)
- No clinical dehydration: Alert, normal skin turgor, moist mucous membranes, normal CRT, normal urine output
- Clinical dehydration: Altered responsiveness, reduced skin turgor, dry mucous membranes, tachycardia, reduced urine output, sunken eyes
- Clinical shock: Decreased consciousness, pale/mottled, cold extremities, CRT >3 sec, tachycardia, hypotension, absent urine output
Red Flags
- Bloody diarrhoea — consider bacterial cause, especially STEC (E. coli O157); avoid antibiotics until STEC excluded
- Bilious (green) vomiting — surgical emergency until proven otherwise (malrotation/volvulus)
- Signs of shock — immediate IV fluid resuscitation
- Severe abdominal pain/distension — consider intussusception, surgical abdomen
- Fever >40°C, rigors, unwell child — consider sepsis, invasive bacterial infection
- Post-diarrhoeal pallor, petechiae, oliguria — haemolytic uraemic syndrome (HUS)
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Viral gastroenteritis | Vomiting preceding diarrhoea, winter, contacts | Clinical; stool virology if needed |
| Bacterial gastroenteritis | Bloody diarrhoea, high fever, travel | Stool MC&S |
| Urinary tract infection | Fever, vomiting, may mimic gastroenteritis | Urine MC&S |
| Appendicitis | RIF pain, anorexia, localised tenderness | USS, surgical review |
| Intussusception | Colicky pain, redcurrant jelly stool, sausage mass | USS (target sign) |
| HUS | Post-diarrhoeal AKI, anaemia, thrombocytopenia | FBC, film, U&Es, LDH |
| Coeliac disease | Chronic diarrhoea, FTT, not acute onset | tTG-IgA |
Diagnosis / Investigation
Bedside
- Clinical assessment of dehydration: Skin turgor, mucous membranes, CRT, HR, level of alertness
- Weight: Compare to recent known weight — % weight loss estimates dehydration severity (~5% = clinical dehydration, ≥10% = shock)
- Urine output monitoring: Wet nappies count, urine dipstick
- Capillary blood glucose: If drowsy or prolonged vomiting
Bloods
- Not routinely required for uncomplicated gastroenteritis (NICE CG84)
- If IV fluids required: U&Es, glucose, blood gas (assess electrolyte disturbance, acidosis)
- If bloody diarrhoea with anaemia/thrombocytopenia: FBC, blood film, U&Es, LDH, haptoglobin (HUS screen)
Imaging
- Not routinely indicated
- Abdominal USS: If intussusception suspected (target/doughnut sign)
Special Tests
- Stool MC&S: If bloody diarrhoea, immunocompromised, recent travel, symptoms >7 days, suspected STEC
- Stool virology: Rotavirus/norovirus/adenovirus rapid antigen testing
- E. coli O157/STEC screen: PCR or culture; do NOT give antibiotics until result available
- Stool ova and parasites: If travel to endemic areas or persistent diarrhoea
Management
Non-pharmacological
- Oral rehydration: ORS (e.g., Dioralyte) 50ml/kg over 4 hours for clinical dehydration (NICE CG84); offer frequently in small volumes
- Continue breastfeeding: Do not stop breastfeeding during gastroenteritis
- Early refeeding: Resume normal diet as soon as rehydrated — do not withhold food
- Avoid fruit juice and carbonated drinks: High osmolality worsens diarrhoea
- Hand hygiene: Alcohol gel is NOT effective against norovirus — soap and water required
- Exclusion from school/nursery: 48 hours after last episode of vomiting/diarrhoea
Pharmacological
- IV fluids: 0.9% NaCl 20ml/kg bolus for shock; then replacement of deficit + maintenance over 24 hours
- Ondansetron: 0.15mg/kg (max 4mg) single oral/IV dose — consider if persistent vomiting prevents ORS (off-licence but widely used; NICE supports use)
- Antibiotics: NOT routine. Indicated for: confirmed Shigella (azithromycin 10mg/kg OD × 3 days), cholera, Giardia (metronidazole 7.5mg/kg TDS × 5-7 days), severe salmonella in immunocompromised
- Avoid: Loperamide (contraindicated in children), routine antibiotics, anti-emetics other than ondansetron
Surgical/Interventional
- Not applicable for gastroenteritis
- If HUS develops — supportive care, dialysis if needed
Referral Criteria
- Signs of shock — immediate hospital admission
- Unable to tolerate ORS, persistent vomiting — hospital for IV rehydration
- Bloody diarrhoea with systemic illness — hospital for STEC screen and HUS monitoring
- Age <3 months with temperature ≥38°C — hospital admission
- High-risk features: immunocompromised, comorbidities, malnourished
Prognosis
- Self-limiting in the vast majority: symptoms resolve within 5-7 days (viral) or 7-14 days (bacterial)
- Dehydration mortality: Very low in UK (<1 per million children per year) with appropriate management
- Post-infectious complications: Temporary lactose intolerance (2-6 weeks), post-infectious IBS
- HUS (E. coli O157): Develops in ~5-10% of STEC-infected children; mortality ~3-5%, ~25% have long-term renal sequelae
- Rotavirus vaccine has dramatically reduced severe disease — prevented an estimated 27,000 hospitalisations in the first 3 years post-introduction
Other Relevant Information
NICE CG84 Dehydration Assessment
| Feature | No Dehydration | Clinical Dehydration | Shock |
|---|---|---|---|
| Responsiveness | Alert | Altered | Decreased consciousness |
| Skin turgor | Normal | Reduced | Reduced |
| Eyes | Normal | Sunken | Sunken |
| Mucous membranes | Moist | Dry | Dry |
| CRT | <2 sec | Prolonged | >3 sec |
| Heart rate | Normal | Tachycardia | Tachycardia |
| Urine output | Normal | Reduced | Absent |
| Estimated fluid deficit | <5% | 5-10% | >10% |
UK Rotavirus Vaccination Schedule
| Dose | Age | Vaccine |
|---|---|---|
| 1st dose | 8 weeks | Rotarix (oral, live) |
| 2nd dose | 12 weeks | Rotarix (oral, live) |
| Must complete by | 24 weeks | — |